SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-053548
Filing Date
2024-05-06
Accepted
2024-05-06 16:09:53
Documents
63
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q rani-20240331.htm   iXBRL 10-Q 1362777
2 EX-31.1 rani-ex31_1.htm EX-31.1 16032
3 EX-31.2 rani-ex31_2.htm EX-31.2 16069
4 EX-32.1 rani-ex32_1.htm EX-32.1 9899
  Complete submission text file 0000950170-24-053548.txt   7299327

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT rani-20240331.xsd EX-101.SCH 1559979
66 EXTRACTED XBRL INSTANCE DOCUMENT rani-20240331_htm.xml XML 1168323
Mailing Address 2051 RINGWOOD AVENUE SAN JOSE CA 95131
Business Address 2051 RINGWOOD AVENUE SAN JOSE CA 95131 (408) 457-3700
Rani Therapeutics Holdings, Inc. (Filer) CIK: 0001856725 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40672 | Film No.: 24917567
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)